Page last updated: 2024-10-21

phenytoin and Dyslipidemias

phenytoin has been researched along with Dyslipidemias in 1 studies

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research Excerpts

ExcerptRelevanceReference
"After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme-inducer AEDs (EIAEDs), especially phenytoin (PHT), were associated with higher prevalence of dyslipidemia (PRa 1."3.85Prevalence of cardiovascular risk factors in people with epilepsy. ( Díez, L; Elosua, R; Gomez, A; Moreira, A; Roquer, J; Vivanco-Hidalgo, RM, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vivanco-Hidalgo, RM1
Gomez, A1
Moreira, A1
Díez, L1
Elosua, R1
Roquer, J1

Other Studies

1 other study available for phenytoin and Dyslipidemias

ArticleYear
Prevalence of cardiovascular risk factors in people with epilepsy.
    Brain and behavior, 2017, Volume: 7, Issue:2

    Topics: Adult; Aged; Anticonvulsants; Cardiovascular Diseases; Comorbidity; Dyslipidemias; Epilepsy; Female;

2017